Weighted Average Number of Shares Outstanding, Basic of LIGAND PHARMACEUTICALS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2010 to Q3 2025.
  • Ligand Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 19.6M shares, a 6.29% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 18.3M shares, a 5.74% increase from 2023.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.3M shares, a 2.55% increase from 2022.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16.9M shares, a 1.43% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 19.6M +1.16M +6.29% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 19.3M +1.3M +7.21% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 19.2M +1.46M +8.23% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 18.3M +992K +5.74% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 18.4M +1.04M +5.98% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 18M +752K +4.35% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 17.7M +669K +3.92% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 17.3M +408K +2.42% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 17.4M +492K +2.91% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 17.3M +408K +2.42% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 17.1M +239K +1.42% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 16.9M +157K +0.94% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023
Q3 2022 16.9M +200K +1.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 16.9M +209K +1.26% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 16.8M +389K +2.37% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 16.7M +656K +4.08% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 16.7M +606K +3.77% 01 Jul 2021 30 Sep 2021 10-K 28 Feb 2023
Q2 2021 16.7M +604K +3.76% 01 Apr 2021 30 Jun 2021 10-K 28 Feb 2023
Q1 2021 16.4M -94K -0.57% 01 Jan 2021 31 Mar 2021 10-K 28 Feb 2023
Q4 2020 16.1M -1.17M -6.76% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021
Q3 2020 16.1M -2.69M -14.3% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 16.1M -3.5M -17.9% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 16.5M -3.92M -19.2% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 17.2M -3.83M -18.2% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 18.8M -2.38M -11.2% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021
Q2 2019 19.6M -1.65M -7.8% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021
Q1 2019 20.4M -762K -3.59% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021
Q4 2018 21.1M 0 0% 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 21.1M 0 0% 01 Jul 2018 30 Sep 2018 10-K 27 Feb 2020
Q2 2018 21.2M 0 0% 01 Apr 2018 30 Jun 2018 10-K 27 Feb 2020
Q1 2018 21.2M 0 0% 01 Jan 2018 31 Mar 2018 10-K 27 Feb 2020
Q4 2017 21.1M +173K +0.83% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 21.1M +261K +1.25% 01 Jul 2017 30 Sep 2017 10-K 28 Feb 2019
Q2 2017 21.2M +380K +1.82% 01 Apr 2017 30 Jun 2017 10-K 28 Feb 2019
Q1 2017 21.2M +501K +2.42% 01 Jan 2017 31 Mar 2017 10-K 28 Feb 2019
Q4 2016 20.9M +965K +4.84% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 20.9M +1M +5.03% 01 Jul 2016 30 Sep 2016 10-K 01 Mar 2018
Q2 2016 20.8M +1.11M +5.61% 01 Apr 2016 30 Jun 2016 10-K 01 Mar 2018
Q1 2016 20.7M +1.1M +5.59% 01 Jan 2016 31 Mar 2016 10-K 01 Mar 2018
Q4 2015 19.9M +55K +0.28% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 19.9M -530K -2.6% 01 Jul 2015 30 Sep 2015 10-K 28 Feb 2017
Q2 2015 19.7M -1.01M -4.89% 01 Apr 2015 30 Jun 2015 10-K 28 Feb 2017
Q1 2015 19.6M -989K -4.8% 01 Jan 2015 31 Mar 2015 10-K 28 Feb 2017
Q4 2014 19.9M -565K -2.76% 01 Oct 2014 31 Dec 2014 10-K 14 Nov 2016
Q3 2014 20.4M +59.4K +0.29% 01 Jul 2014 30 Sep 2014 10-K 14 Nov 2016
Q2 2014 20.7M +479K +2.37% 01 Apr 2014 30 Jun 2014 10-K 14 Nov 2016
Q1 2014 20.6M +412K +2.04% 01 Jan 2014 31 Mar 2014 10-K 14 Nov 2016
Q4 2013 20.4M +408K +2.04% 01 Oct 2013 31 Dec 2013 10-K 23 Feb 2015
Q3 2013 20.4M +440K +2.21% 01 Jul 2013 30 Sep 2013 10-K 23 Feb 2015
Q2 2013 20.3M +509K +2.58% 01 Apr 2013 30 Jun 2013 10-K 23 Feb 2015
Q1 2013 20.2M +480K +2.44% 01 Jan 2013 31 Mar 2013 10-K 23 Feb 2015
Q4 2012 20M +360K +1.83% 01 Oct 2012 31 Dec 2012 10-K/A 12 Dec 2014
Q3 2012 19.9M +245K +1.24% 01 Jul 2012 30 Sep 2012 10-K/A 12 Dec 2014
Q2 2012 19.7M +99.3K +0.51% 01 Apr 2012 30 Jun 2012 10-K/A 12 Dec 2014
Q1 2012 19.7M +86.1K +0.44% 01 Jan 2012 31 Mar 2012 10-K/A 12 Dec 2014
Q4 2011 19.7M 01 Oct 2011 31 Dec 2011 10-K 14 Mar 2013
Q3 2011 19.7M +43.3K +0.22% 01 Jul 2011 30 Sep 2011 10-K 14 Mar 2013
Q2 2011 19.7M +41.3K +0.21% 01 Apr 2011 30 Jun 2011 10-K 14 Mar 2013
Q1 2011 19.6M 01 Jan 2011 31 Mar 2011 10-K 14 Mar 2013
Q3 2010 19.6M 01 Jul 2010 30 Sep 2010 10-Q/A 10 Feb 2012
Q2 2010 19.6M 01 Apr 2010 30 Jun 2010 10-Q/A 10 Feb 2012

LIGAND PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 18.3M +992K +5.74% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 17.3M +430K +2.55% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 16.9M +238K +1.43% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 16.6M +445K +2.75% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 16.2M -2.81M -14.8% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 19M -2.17M -10.2% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 21.2M +128K +0.61% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 21M +201K +0.97% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 20.8M +1.04M +5.26% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 19.8M -629K -3.08% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018
2014 20.4M +107K +0.53% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 20.3M +459K +2.31% 01 Jan 2013 31 Dec 2013 10-K 14 Nov 2016
2012 19.9M +197K +1.01% 01 Jan 2012 31 Dec 2012 10-K 23 Feb 2015
2011 19.7M +42.4K +0.22% 01 Jan 2011 31 Dec 2011 10-K/A 12 Dec 2014
2010 19.6M 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.